Lincoln Pharmaceuticals Limited (BOM:531633)
India flag India · Delayed Price · Currency is INR
615.55
-1.45 (-0.24%)
At close: Mar 9, 2026

Lincoln Pharmaceuticals Balance Sheet

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020 - 2016
Cash & Equivalents
-134.1457.4750.5269.34138.41
Upgrade
Short-Term Investments
-85.7777.83116.57113.82-
Upgrade
Trading Asset Securities
-1,7371,389913.26968.06806.65
Upgrade
Cash & Short-Term Investments
2,3191,9571,5241,0801,151945.06
Upgrade
Cash Growth
17.48%28.38%41.11%-6.16%21.81%103.47%
Upgrade
Accounts Receivable
-1,6641,6181,3631,1591,133
Upgrade
Other Receivables
-1.670.641.353.42.06
Upgrade
Receivables
-2,0271,9221,6041,4901,333
Upgrade
Inventory
-786.77771.68700.28727.42466.13
Upgrade
Prepaid Expenses
-18.0916.2519.363.7311.37
Upgrade
Other Current Assets
-210.75143.83268.29156.19331.8
Upgrade
Total Current Assets
-4,9994,3783,6723,5283,088
Upgrade
Property, Plant & Equipment
-1,8601,8251,5691,4761,119
Upgrade
Long-Term Investments
-0.030.040.030.031.04
Upgrade
Other Intangible Assets
-4.43.262.953.833.98
Upgrade
Other Long-Term Assets
-43.0747.6333.7465.1559.76
Upgrade
Total Assets
-7,9707,0035,8745,3444,524
Upgrade
Accounts Payable
-849.48724.4508.67716.67570.66
Upgrade
Accrued Expenses
-99.7590.0682.9270.1458.49
Upgrade
Short-Term Debt
--10.6719.9720.44-
Upgrade
Current Portion of Long-Term Debt
-----3.75
Upgrade
Current Income Taxes Payable
--0.718.8242.7731.59
Upgrade
Other Current Liabilities
-112.9396.93101.0854.8593.91
Upgrade
Total Current Liabilities
-1,062922.77721.45904.86758.4
Upgrade
Long-Term Debt
-----1.45
Upgrade
Long-Term Unearned Revenue
-53.8536.2547.2145.3942.92
Upgrade
Pension & Post-Retirement Benefits
-7.340.971.39--
Upgrade
Long-Term Deferred Tax Liabilities
-130.02114.5679.4164.5556.91
Upgrade
Total Liabilities
-1,2531,075849.461,015859.67
Upgrade
Common Stock
-200.3200.3200.3200.3200.3
Upgrade
Additional Paid-In Capital
-646.17646.17646.17646.17646.17
Upgrade
Retained Earnings
-5,9695,1824,2793,5802,916
Upgrade
Comprehensive Income & Other
--99.15-100.06-100.67-97.7-99
Upgrade
Total Common Equity
7,1586,7175,9285,0254,3293,664
Upgrade
Shareholders' Equity
7,1586,7175,9285,0254,3293,664
Upgrade
Total Liabilities & Equity
-7,9707,0035,8745,3444,524
Upgrade
Total Debt
0.67-10.6719.9720.445.2
Upgrade
Net Cash (Debt)
2,3181,9571,5141,0601,131939.86
Upgrade
Net Cash Growth
18.25%29.28%42.76%-6.22%20.31%127.17%
Upgrade
Net Cash Per Share
115.7597.7175.5852.9456.4646.92
Upgrade
Filing Date Shares Outstanding
20.0320.0320.0320.0320.0320
Upgrade
Total Common Shares Outstanding
20.0320.0320.0320.0320.0320
Upgrade
Working Capital
-3,9373,4552,9512,6242,329
Upgrade
Book Value Per Share
357.45335.34295.98250.86216.12183.20
Upgrade
Tangible Book Value
7,1536,7125,9255,0224,3253,660
Upgrade
Tangible Book Value Per Share
357.22335.12295.82250.72215.93183.00
Upgrade
Land
-200.24200.24187.36186.32172.57
Upgrade
Buildings
-626.46602.21580.66478.61357.92
Upgrade
Machinery
-1,6751,5481,1921,031875.31
Upgrade
Construction In Progress
-44.734.8367.14160.5416.86
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.